Townsquare Capital LLC Purchases 9,165 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Townsquare Capital LLC lifted its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 8.6% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 116,095 shares of the medical device company's stock after buying an additional 9,165 shares during the period. Townsquare Capital LLC owned about 0.06% of Cooper Companies worth $10,673,000 at the end of the most recent quarter.

Several other hedge funds also recently modified their holdings of the stock. Byrne Asset Management LLC acquired a new stake in Cooper Companies in the fourth quarter valued at $33,000. OFI Invest Asset Management acquired a new stake in Cooper Companies in the 4th quarter valued at about $34,000. New Age Alpha Advisors LLC bought a new position in Cooper Companies during the fourth quarter worth about $38,000. Covestor Ltd increased its position in Cooper Companies by 35.5% during the fourth quarter. Covestor Ltd now owns 458 shares of the medical device company's stock worth $42,000 after buying an additional 120 shares during the last quarter. Finally, West Financial Advisors LLC acquired a new position in Cooper Companies during the fourth quarter worth approximately $49,000. Institutional investors own 24.39% of the company's stock.

Wall Street Analysts Forecast Growth

Several research analysts have recently commented on the company. Robert W. Baird reduced their target price on Cooper Companies from $117.00 to $107.00 and set an "outperform" rating for the company in a research note on Friday, March 7th. BNP Paribas raised shares of Cooper Companies to a "hold" rating in a research report on Thursday, March 13th. Citigroup dropped their price objective on shares of Cooper Companies from $115.00 to $110.00 and set a "buy" rating on the stock in a research report on Friday, March 7th. JPMorgan Chase & Co. reduced their target price on shares of Cooper Companies from $120.00 to $110.00 and set an "overweight" rating for the company in a report on Friday, March 7th. Finally, Piper Sandler reissued an "overweight" rating and issued a $115.00 price target (down from $120.00) on shares of Cooper Companies in a report on Friday, March 7th. Four analysts have rated the stock with a hold rating and seven have given a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $110.25.

Remove Ads

Cooper Companies Price Performance

Shares of NASDAQ COO traded down $0.96 during mid-day trading on Tuesday, reaching $77.80. The company had a trading volume of 1,386,329 shares, compared to its average volume of 1,399,687. The firm has a market cap of $15.56 billion, a price-to-earnings ratio of 39.90, a PEG ratio of 2.25 and a beta of 1.01. The business's 50-day simple moving average is $83.93 and its 200 day simple moving average is $94.19. The Cooper Companies, Inc. has a one year low of $69.81 and a one year high of $112.38. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91.

Cooper Companies (NASDAQ:COO - Get Free Report) last released its earnings results on Thursday, March 6th. The medical device company reported $0.92 EPS for the quarter, meeting the consensus estimate of $0.92. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The firm had revenue of $964.70 million for the quarter, compared to analyst estimates of $981.25 million. On average, research analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.